GENEPHARM AMLODIPINE amlodipine 10 mg (as besilate) tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

amlodipine besilate, Quantity: 14 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

amlodipine besilate

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: maize starch; lactose monohydrate; microcrystalline cellulose; magnesium stearate

Administration route:

Oral

Units in package:

30 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Hypertension - Genepharm Amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of Genepharm Amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. Angina - Genepharm Amlodipine is indicated for the first line treatment of chronic stable angina. Genepharm Amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

Product summary:

Visual Identification: White to off white, round, unscored tablets, engraved APO on one side and AML over 10 on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2007-12-13